BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 30411380)

  • 21. Amphiregulin inhibits TNF-α-induced alveolar epithelial cell death through EGFR signaling pathway.
    Meng C; Wang S; Wang X; Lv J; Zeng W; Chang R; Li Q; Wang X
    Biomed Pharmacother; 2020 May; 125():109995. PubMed ID: 32187954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
    Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism.
    Hu X; Bonde Y; Eggertsen G; Rudling M
    J Intern Med; 2014 Jan; 275(1):27-38. PubMed ID: 24118394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis.
    Svinka J; Pflügler S; Mair M; Marschall HU; Hengstler JG; Stiedl P; Poli V; Casanova E; Timelthaler G; Sibilia M; Eferl R
    J Mol Med (Berl); 2017 Jan; 95(1):109-117. PubMed ID: 27568040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
    Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
    Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting FXR in Cholestasis.
    Keitel V; Dröge C; Häussinger D
    Handb Exp Pharmacol; 2019; 256():299-324. PubMed ID: 31201556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-210 Promotes Bile Acid-Induced Cholestatic Liver Injury by Targeting Mixed-Lineage Leukemia-4 Methyltransferase in Mice.
    Kim YC; Jung H; Seok S; Zhang Y; Ma J; Li T; Kemper B; Kemper JK
    Hepatology; 2020 Jun; 71(6):2118-2134. PubMed ID: 31549733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats.
    Zhang F; Xi L; Duan Y; Qin H; Wei M; Wu Y; Li B; Zhou Y; Wu X
    Eur J Pharm Sci; 2018 Oct; 123():404-415. PubMed ID: 30077711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yinchenzhufu decoction protects against alpha-naphthylisothiocyanate-induced acute cholestatic liver injury in mice by ameliorating disordered bile acid homeostasis and inhibiting inflammatory responses.
    Wang GF; Li YY; Shi R; Wang TM; Li YF; Li WK; Zheng M; Fan FB; Zou J; Zan B; Wu JS; Ma YM
    J Ethnopharmacol; 2020 May; 254():112672. PubMed ID: 32084553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nontumorigenic variant of FGF19 treats cholestatic liver diseases.
    Luo J; Ko B; Elliott M; Zhou M; Lindhout DA; Phung V; To C; Learned RM; Tian H; DePaoli AM; Ling L
    Sci Transl Med; 2014 Jul; 6(247):247ra100. PubMed ID: 25080475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
    Meadows V; Marakovits C; Ekser B; Kundu D; Zhou T; Kyritsi K; Pham L; Chen L; Kennedy L; Ceci L; Wu N; Carpino G; Zhang W; Isidan A; Meyer A; Owen T; Gaudio E; Onori P; Alpini G; Francis H
    Am J Physiol Gastrointest Liver Physiol; 2023 Jan; 324(1):G60-G77. PubMed ID: 36410025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr/Nrf2 and CHOP-DR5-caspase-8 pathway.
    Song G; Weng F; Zou B; Zhao J; Jin J; Yan D; Huang K; Sun X; Liu C; Hu Y; Li Y; Qiu F
    Clin Sci (Lond); 2023 Apr; 137(7):561-577. PubMed ID: 36795945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Constitutive Androstane Receptor (CAR) in Mice Results in Maintained Biliary Excretion of Bile Acids Despite a Marked Decrease of Bile Acids in Liver.
    Lickteig AJ; Csanaky IL; Pratt-Hyatt M; Klaassen CD
    Toxicol Sci; 2016 Jun; 151(2):403-18. PubMed ID: 26984780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis.
    Thompson MD; Moghe A; Cornuet P; Marino R; Tian J; Wang P; Ma X; Abrams M; Locker J; Monga SP; Nejak-Bowen K
    Hepatology; 2018 Mar; 67(3):955-971. PubMed ID: 28714273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids.
    Nagathihalli NS; Beesetty Y; Lee W; Washington MK; Chen X; Lockhart AC; Merchant NB
    Cancer Res; 2014 Apr; 74(7):2062-72. PubMed ID: 24520077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice.
    Almishri W; Swain LA; D'Mello C; Le TS; Urbanski SJ; Nguyen HH
    Front Immunol; 2021; 12():779119. PubMed ID: 35095853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
    He H; Mennone A; Boyer JL; Cai SY
    Hepatology; 2011 Feb; 53(2):548-57. PubMed ID: 21274875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease.
    Blokker BA; Maijo M; Echeandia M; Galduroz M; Patterson AM; Ten A; Philo M; Schungel R; Gutierrez-de Juan V; Halilbasic E; Fuchs C; Le Gall G; Milkiewicz M; Milkiewicz P; Banales JM; Rushbrook SM; Mato JM; Trauner M; Müller M; Martínez-Chantar ML; Varela-Rey M; Beraza N
    Hepatology; 2019 Feb; 69(2):699-716. PubMed ID: 30229970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats.
    Duan Y; Zhang F; Yuan W; Wei Y; Wei M; Zhou Y; Yang Y; Chang Y; Wu X
    Life Sci; 2019 Sep; 232():116638. PubMed ID: 31288013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docosahexaenoic acid enhances amphiregulin-mediated bronchial epithelial cell repair processes following organic dust exposure.
    Nordgren TM; Heires AJ; Bailey KL; Katafiasz DM; Toews ML; Wichman CS; Romberger DJ
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L421-L431. PubMed ID: 29097425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.